Treatment with allopurinol and itraconazole changes lytic activity in patients with chronic, low grade Trypanosoma cruzi infection.
Sánchez
G
G
Department of Biochemistry, Faculty of Medicine, University of Chile, Santiago, Chile.
Zulantay
I
I
Venegas
J
J
Solari
A
A
Gálvez
R
R
Peña
P
P
Rodríguez
J
J
Apt
W
W
D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use*; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D014355:Chagas Disease / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D008875:Middle Aged
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D017964:Itraconazole; D000493:Allopurinol